Table 5 Laboratory data before and after treatment: it showed a statistically significant improvement (decrease) in AST, ALT, and APRI score, but no statistically significant change in platelet count and FIB4 score

AST

33 (24–44)

24.5 (22–30)

− 3.662

< 0.0005

ALT

37 (22–64)

24.5 (21–29)

− 3.583

< 0.0005

Platelet count

175 (124–228)

177.5 (145–219)

− 0.479

0.632

APRI score

0.52 (0.25–0.85)

0.37 (0.24–0.55)

− 3.889

< 0.0005

FIB4 score

1.7 (0.91–2.72)

1.6 (0.87–2.26)

− 1.564

0.118